Atlas Trials

Letrozole Plus Oral Cyclophosphamide Plus/Minus Sorafenib as Primary Systemic Treatment in Breast Cancer Patients

Clinical trial NCT00954135 · UNKNOWN

Trial details

NCT number
NCT00954135
Sponsor
University of Turin, Italy
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Breast Cancer
Start date
2007-09-01
Primary completion
2010-06-01
Enrollment
190

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.